52 results
S-8
EX-99.1
GYRE
Gyre Therapeutics Inc
30 Oct 23
Registration of securities for employees
5:46pm
, the Grantee’s name, account information, social security number, tax number and contact information. The Company may process such personal data in its
8-K
EX-14.1
GYRE
Gyre Therapeutics Inc
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
the intellectual property rights of others. We strongly encourage all directors, officers and employees to avoid references to the Company on social
8-K
EX-10.2
GYRE
Gyre Therapeutics Inc
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
, the Grantee’s name, account information, social security number, tax number and contact information. The Company may process such personal data in its
8-K
GYRE
Gyre Therapeutics Inc
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
of professor-level senior engineer from Zhejiang Province Human Resources and Social Security Department in June 2015.
Han Ying, Ph.D. (Age 58). Dr. Ying
DEFM14A
rse5bm65jiy5u0sr3tz
20 Jul 23
Proxy related to merger
8:57am
PRER14A
2bixu27
15 May 23
Preliminary revised proxy
4:02pm
PREM14A
3fmiej
30 Mar 23
Preliminary proxy related to merger
4:48pm
425
EX-2.1
6pzu nius
27 Dec 22
Business combination disclosure
7:02am
425
EX-2.2
su90 hqy66
27 Dec 22
Business combination disclosure
7:02am
8-K
EX-2.1
14nipqr05 7eq1
27 Dec 22
Catalyst Biosciences Completes First Steps in Reverse Merger Plan
7:00am
8-K
EX-2.2
1gt3v
27 Dec 22
Catalyst Biosciences Completes First Steps in Reverse Merger Plan
7:00am
DEFC14A
jcupv08grebvwwz
20 Jul 22
Proxy in contested solicitation
9:16am
DEFC14A
47wghgngw3 0kj3tk
19 Jul 22
Proxy in contested solicitation
8:01am
PRRN14A
r2tzx81yo ts
18 Jul 22
Revised preliminary proxy statement filed by non-management
5:07pm
PRRN14A
opfkncqwqhu 0s
14 Jul 22
Revised preliminary proxy statement filed by non-management
5:21pm
PREC14A
rfespn
8 Jul 22
Preliminary proxy with contested solicitation
3:51pm